Literature DB >> 21503949

Intersectin1-s is involved in migration and invasion of human glioma cells.

Yongjie Ma1, Bingbing Wang, Wenliang Li, Xiaoli Liu, Jing Wang, Ting Ding, Jiao Zhang, Guoguang Ying, Li Fu, Feng Gu.   

Abstract

Malignant gliomas have a tendency to invade diffusely into surrounding healthy brain tissues, thereby precluding their successful surgical removal. Intersectin1 (ITSN1) as a molecular linker in the central nervous system is well known as an important regulator of endocytosis and exocytosis. ITSN1 has two isoforms: ITSN1-l and ITSN1-s. In this study, we show that siRNA-mediated down regulation of ITSN1-s inhibited migration and invasion of glioma cells. In addition, we demonstrate the possible mechanisms by which ITSN1-s functions in migration and invasion. Several key proteins, including cofilin, LIMK, PAK, FAK, integrin β1, and MMP-9, which are critical for cells migration and invasion, were probably involved in ITSN1-s signaling pathways. These results suggest that ITSN1-s contributes to glioma cells migration and invasion by regulating the formation of cytoskeleton, influencing adhesion and increasing expression of MMP-9. Our results indicate that ITSN1-s is a critical factor in gliomas invasion and identify that ITSN1-s is a new potentially antiinvasion target for therapeutic intervention in gliomas.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503949     DOI: 10.1002/jnr.22616

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

1.  LncRNA and mRNA interaction study based on transcriptome profiles reveals potential core genes in the pathogenesis of human glioblastoma multiforme.

Authors:  Yong Yan; Lei Zhang; Ying Jiang; Tao Xu; Qiyong Mei; Hongxiang Wang; Rong Qin; Yongxiang Zou; Guohan Hu; Juxiang Chen; Yicheng Lu
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-07       Impact factor: 4.553

2.  Altered Expression of Intersectin1-L in Patients with Refractory Epilepsy and in Experimental Epileptic Rats.

Authors:  Xiaoyan Yang; Xin Xu; Yujiao Zhang; Shasha Wang; Minghui Li; Xuefeng Wang
Journal:  Cell Mol Neurobiol       Date:  2015-03-18       Impact factor: 5.046

Review 3.  Intersectin scaffold proteins and their role in cell signaling and endocytosis.

Authors:  Erika Herrero-Garcia; John P O'Bryan
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2016-10-12       Impact factor: 4.739

4.  Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2β) isoform contributes to neuroblastoma tumorigenesis.

Authors:  Angela Russo; Mustafa Nazir Okur; Maarten Bosland; John P O'Bryan
Journal:  Cancer Lett       Date:  2015-01-23       Impact factor: 8.679

5.  Intersectin-s interaction with DENND2B facilitates recycling of epidermal growth factor receptor.

Authors:  Maria S Ioannou; Gopinath Kulasekaran; Maryam Fotouhi; Justin J Morein; Chanshuai Han; Sarah Tse; Nadya Nossova; Tony Han; Erin Mannard; Peter S McPherson
Journal:  EMBO Rep       Date:  2017-10-13       Impact factor: 8.807

Review 6.  Systematic review of protein biomarkers of invasive behavior in glioblastoma.

Authors:  Eli T Sayegh; Gurvinder Kaur; Orin Bloch; Andrew T Parsa
Journal:  Mol Neurobiol       Date:  2013-11-24       Impact factor: 5.590

7.  Intersectin 1 is required for neuroblastoma tumorigenesis.

Authors:  A Russo; J P O'Bryan
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

8.  Increasing radiosensitivity with the downregulation of cofilin-1 in U251 human glioma cells.

Authors:  Hua-Qing Du; Ling Chen; Ying Wang; Li-Jun Wang; Hua Yan; Hong-Yi Liu; Hong Xiao
Journal:  Mol Med Rep       Date:  2014-12-22       Impact factor: 2.952

9.  Effects of β4 integrin expression on microRNA patterns in breast cancer.

Authors:  Kristin D Gerson; V S R Krishna Maddula; Bruce E Seligmann; Jeffrey R Shearstone; Ashraf Khan; Arthur M Mercurio
Journal:  Biol Open       Date:  2012-05-25       Impact factor: 2.422

Review 10.  Emerging roles for intersectin (ITSN) in regulating signaling and disease pathways.

Authors:  Michael P Hunter; Angela Russo; John P O'Bryan
Journal:  Int J Mol Sci       Date:  2013-04-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.